|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kang CG, Lee HJ, Kim SH and Lee EO:
Zerumbone suppresses osteopontin-induced cell invasion through
inhibiting the FAK/AKT/ROCK pathway in human non-small cell lung
cancer A549 Cells. J Nat Prod. 79:156–160. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xu YJ, Du Y and Fan Y: Long noncoding RNAs
in lung cancer: What we know in 2015. Clin Transl Oncol.
18:660–665. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
She J, Yang P, Hong Q and Bai C: Lung
cancer in China: Challenges and interventions. Chest.
143:1117–1126. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu Q and Zhou Q: The challenges of lung
cancer in China. J Cancer Res Ther. 9 (Suppl 2):S65–S66. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Nakanishi K, Mizuno T, Sakakura N, Kuroda
H, Shimizu J, Hida T, Yatabe Y and Sakao Y: Salvage surgery for
small cell lung cancer after chemoradiotherapy. Jpn J Clin Oncol.
1:389–392. 2019. View Article : Google Scholar
|
|
7
|
Gamazon ER, Trendowski MR, Wen Y, Wing C,
Delaney SM, Huh W, Wong S, Cox NJ and Dolan ME: Gene and MicroRNA
perturbations of cellular response to pemetrexed implicate
biological networks and enable imputation of response in lung
adenocarcinoma. Sci Rep. 8:7332018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Inoue K: MicroRNA function in animal
development. Tanpakushitsu Kakusan Koso. 52:197–204. 2007.(In
Japanese). PubMed/NCBI
|
|
9
|
Liu G, Li YI and Gao X: Overexpression of
microRNA-133b sensitizes non-small cell lung cancer cells to
irradiation through the inhibition of glycolysis. Oncol Lett.
11:2903–2908. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jiang LP, Zhu ZT and He CY: Expression of
miRNA-26b in the diagnosis and prognosis of patients with
non-small-cell lung cancer. Future Oncol. 12:1105–1115. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Fan Y, Li H, Ma X, Go Y, Bao X, Du Q, Ma
M, Liu K, Yao Y, Huang Q, et al: Dicer suppresses the malignant
phenotype in VHL-deficient clear cell renal cell carcinoma by
inhibiting HIF-2α. Oncotarget. 7:18280–18294. 2016.PubMed/NCBI
|
|
12
|
Assal RA, El Tayebi HM, Hosny KA, Esmat G
and Abdelaziz AI: A pleiotropic effect of the single clustered
hepatic metastamiRs miR-96-5p and miR-182-5p on insulin-like growth
factor II, insulin-like growth factor-1 receptor and insulin-like
growth factor-binding protein-3 in hepatocellular carcinoma. Mol
Med Rep. 12:645–650. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Dorstyn L, Puccini J, Wilson CH, Shalini
S, Nicola M, Moore S and Kumar S: Caspase-2 deficiency promotes
aberrant DNA-damage response and genetic instability. Cell Death
Differ. 19:1288–1298. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Y, Liu C, Wang J, Zhang Y and Chen L:
Iodine-131 induces apoptosis in human cardiac muscle cells through
the p53/Bax/caspase-3 and PIDD/caspase-2/tBID/cytochrome
c/caspase-3 signaling pathway. Oncol Rep. 38:1579–1586. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jang TH, Lee SJ, Woo CH, Lee KJ, Jeon JH,
Lee DS, Choi K, Kim IG, Kim YW, Lee TJ and Park HH: Inhibition of
genotoxic stress induced apoptosis by novel TAT-fused peptides
targeting PIDDosome. Biochem Pharmacol. 83:218–227. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu J, Dou Y and Sheng M: Inhibition of
microRNA-383 has tumor suppressive effect in human epithelial
ovarian cancer through the action on caspase-2 gene. Biomed
Pharmacother. 83:1286–1294. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Makwana K, Patel SA, Velingkaar N, Ebron
JS, Shukla GC and Kondratov RVKV: Aging and calorie restriction
regulate the expression of miR-125a-5p and its target genes Stat3,
Casp2 and Stard13. Aging (Albany NY). 9:1825–1843. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Xia D, Li X, Niu Q, Liu X, Xu W, Ma C, Gu
H, Liu Z, Shi L, Tian X, et al: MicroRNA-185 suppresses pancreatic
cell proliferation by targeting transcriptional coactivator with
PDZ-binding motif in pancreatic cancer. Exp Ther Med. 15:657–666.
2018.PubMed/NCBI
|
|
19
|
He X, Ping J and Wen D: MicroRNA-186
regulates the invasion and metastasis of bladder cancer via
vascular endothelial growth factor C. Exp Ther Med. 14:3253–3258.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Arocho A, Chen B, Ladanyi M and Pan Q:
Validation of the 2-DeltaDeltaCt calculation as an alternate method
of data analysis for quantitative PCR of BCR-ABL P210 transcripts.
Diagn Mol Pathol. 15:56–61. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Oser MG, Niederst MJ, Sequist LV and
Engelman JA: Transformation from non-small-cell lung cancer to
small-cell lung cancer: Molecular drivers and cells of origin.
Lancet Oncol. 16:e165–e172. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen G, Umelo IA, Lv S, Teugels E, Fostier
K, Kronenberger P, Dewaele A, Sadones J, Geers C and De Greve J:
miR-146a inhibits cell growth, cell migration and induces apoptosis
in non-small cell lung cancer cells. PLoS One. 8:e603172013.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hofman P: The challenges of evaluating
predictive biomarkers using small biopsy tissue samples and liquid
biopsies from non-small cell lung cancer patients. J Thorac Dis. 11
(Suppl 1):S57–S64. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Castanon E, Martin P, Rolfo C, Fusco JP,
Ceniceros L, Legaspi J, Santisteban M and Gil-Bazo I: Epidermal
growth factor receptor targeting in non-small cell lung cancer:
Revisiting different strategies against the same target. Curr Drug
Targets. 15:1273–1283. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chen G, Kronenberger P, Teugels E, Umelo
IA and De Greve J: Effect of siRNAs targeting the EGFR T790M
mutation in a non-small cell lung cancer cell line resistant to
EGFR tyrosine kinase inhibitors and combination with various
agents. Biochem Biophys Res Commun. 431:623–629. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Chen G, Kronenberger P, Teugels E, Umelo
IA and De Greve J: Targeting the epidermal growth factor receptor
in non-small cell lung cancer cells: The effect of combining RNA
interference with tyrosine kinase inhibitors or cetuximab. BMC Med.
10:282012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen G, Noor A, Kronenberger P, Teugels E,
Umelo IA and De Greve J: Synergistic effect of afatinib with
su11274 in non-small cell lung cancer cells resistant to gefitinib
or erlotinib. PLoS One. 8:e597082013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lan D, Zhang X, He R, Tang R, Li P, He Q
and Chen G: MiR-133a is downregulated in non-small cell lung
cancer: A study of clinical significance. Eur J Med Res. 20:502015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang X, Li P, Rong M, He R, Hou X, Xie Y
and Chen G: MicroRNA-141 is a biomarker for progression of squamous
cell carcinoma and adenocarcinoma of the lung: Clinical analysis of
125 patients. Tohoku J Exp Med. 235:161–169. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Rihani A, Van Goethem A, Ongenaert M, De
Brouwer S, Volders PJ, Agarwal S, De Preter K, Mestdagh P, Shohet
J, Speleman F, et al: Genome wide expression profiling of p53
regulated miRNAs in neuroblastoma. Sci Rep. 5:90272015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chen L, Ma H, Hu H, Gao L, Wang X, Ma J,
Gao Q, Liu B, Zhou G and Liang C: Special role of Foxp3 for the
specifically altered microRNAs in Regulatory T cells of HCC
patients. BMC Cancer. 14:4892014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xu X, Wu J, Li S, Hu Z, Xu X, Zhu Y, Liang
Z, Wang X, Lin Y, Mao Y, et al: Downregulation of microRNA-182-5p
contributes to renal cell carcinoma proliferation via activating
the AKT/FOXO3a signaling pathway. Mol Cancer. 13:1092014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang L, Zhu MJ, Ren AM, Wu HF, Han WM, Tan
RY and Tu RQ: A ten-microRNA signature identified from a
genome-wide microRNA expression profiling in human epithelial
ovarian cancer. PLoS One. 9:e964722014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hirata H, Ueno K, Shahryari V, Deng G,
Tanaka Y, Tabatabai ZL, Hinoda Y and Dahiya R: MicroRNA-182-5p
promotes cell invasion and proliferation by down regulating FOXF2,
RECK and MTSS1 genes in human prostate cancer. PLoS One.
8:e555022013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Hirata H, Ueno K, Shahryari V, Tanaka Y,
Tabatabai ZL, Hinoda Y and Dahiya R: Oncogenic miRNA-182-5p targets
Smad4 and RECK in human bladder cancer. PLoS One. 7:e510562012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tsuchiyama K, Ito H, Taga M, Naganuma S,
Oshinoya Y, Nagano K, Yokoyama O and Itoh H: Expression of
microRNAs associated with Gleason grading system in prostate
cancer: miR-182-5p is a useful marker for high grade prostate
cancer. Prostate. 73:827–834. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Suzuki Y and Farbman AI: Tumor necrosis
factor-alpha-induced apoptosis in olfactory epithelium in vitro:
Possible roles of caspase 1 (ICE), caspase 2 (ICH-1), and caspase 3
(CPP32). Exp Neurol. 165:35–45. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Lv XX, Yu XH, Wang HD, Yan YX, Wang YP, Lu
DX, Qi RB, Hu CF and Li HM: Berberine inhibits
norepinephrine-induced apoptosis in neonatal rat cardiomyocytes via
inhibiting ROS-TNF-α-caspase signaling pathway. Chin J Integr Med.
19:424–431. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Droin N, Bichat F, Rebe C, Wotawa A,
Sordet O, Hammann A, Bertrand R and Solary E: Involvement of
caspase-2 long isoform in Fas-mediated cell death of human leukemic
cells. Blood. 97:1835–1844. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Jean YY, Ribe EM, Pero ME, Moskalenko M,
Iqbal Z, Marks LJ, Greene LA and Troy CM: Caspase-2 is essential
for c-Jun transcriptional activation and Bim induction in neuron
death. Biochem J. 455:15–25. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Troy CM, Rabacchi SA, Hohl JB, Angelastro
JM, Greene LA and Shelanski ML: Death in the balance: Alternative
participation of the caspase-2 and −9 pathways in neuronal death
induced by nerve growth factor deprivation. J Neurosci.
21:5007–5016. 2001. View Article : Google Scholar : PubMed/NCBI
|
